HAIRY CELL LEUKEMIA FOUNDATION’s Post

Near early T-precursor lymphoblastic leukemia with marked flower petal nuclei: blast with unique cyanthiform nucleus https://lnkd.in/eaNh7x65

Session 2: Collaboration as the motor to drive changes in childhood leukemia. Jan Trka, from Charles University, presents on the use of collaborative networks to ensure high-quality monitoring of childhood leukemia.

Ravi Vij, Discussing with Dr. Bita Fakhri MD On Treatment of Front-Line Chronic Lymphocytic Leukemia https://lnkd.in/gTvWpzT9 To get full access to this video, join us at https://lnkd.in/dDV7SUE3

https://lnkd.in/gvxYGm3S #BMTinfonet #GVHD #CarTcell #CaringConnections #SurvivorshipSymposium #stemcelltransplantsurvivor #Laura Tiberi #Chronic Myelomonocytic Leukemia

https://lnkd.in/gvxYGm3S #BMTinfonet #GVHD #CarTcell #CaringConnections #SurvivorshipSymposium #stemcelltransplantsurvivor #Laura Tiberi #Chronic Myelomonocytic Leukemia

🔊Today we share the #Article "Cytotoxic Mechanism of Momilactones A and B against Acute Promyelocytic Leukemia and Multiple Myeloma Cell Lines" 🧐by La Hoang Anh, Vu Quang Lam et al. Hiroshima University Find the full paper here▶️ https://lnkd.in/eJKNwE7c Keywords: momilactones; leukemia; multiple myeloma

Lymphoplasmacytoid cytology in plasma cell leukemia . https://lnkd.in/eUxkYxxE

How do the regulatory mechanisms of TAL1 work in T-cell acute lymphoblastic leukemia (T-ALL) cells? Using a powerful protein degradation system, Ong and colleagues provide a comprehensive view of the TAL1-induced transcriptional program in human T-ALL cells. https://lnkd.in/dFFtEXsa

A new chemotherapy-free regimen of olverembatinib in combination with venetoclax and dexamethasone for newly diagnosed Ph+ acute lymphoblastic leukemia https://lnkd.in/dRT-h22s

Check out figure 7 in the discussion section. I love this figure and I had such a great time working on it! It took a while so I almost forgot about it. Such a lovely surprise to see this great paper is finally published!! (Link in the comments)